Slimetry Capsules – 26.15mg

$250.00

26.15mg Total Combination – Oral Capsules

Slimetry Capsules 26.15mg is an advanced, high-purity oral formulation engineered to study multi-pathway lipid beta-oxidation, non-stimulatory resting metabolic acceleration, and hypothalamic satiety synchronization. By concurrently activating intracellular AMPK pathways to trigger white adipose tissue browning kinetics and upregulating mitochondrial ATP turnover rates, this precisely standardized 26.15mg capsule presentation stands as a premier investigative tool for tracking advanced fat mobilization, lean tissue preservation, and attenuated food-seeking behaviors in laboratory models.

Supplied as stable, precisely standardized 26.15mg research capsules. Restricted strictly to laboratory and in vitro evaluation.

Description

Eterna Peptides presents premium-grade Slimetry Capsules (26.15mg), an advanced oral multi-pathway research formulation engineered to study maximum lipid beta-oxidation, non-stimulatory metabolic acceleration, and synchronized appetite attenuation. By uniting precise, high-purity small molecule compounds and cellular modifiers inside a single standardized 26.15mg capsule, this breakthrough matrix serves as an elite investigative tool for tracking white adipose tissue browning kinetics, AMP-activated protein kinase (AMPK) activation, and the preservation of lean skeletal muscle tissue under simulated caloric deficits.

### Advanced 26.15mg Synergistic Metabolic Profile
Each carefully calibrated oral capsule delivers an exact, uniform distribution of targeted research compounds engineered to optimize cellular energy expenditure:
* **AMPK & Sirtuin Axis Activators:** Formulated to mimic the cellular signaling pathways typically triggered by absolute energetic stress and physical fasting, driving glucose uptake and fat oxidation without demanding systemic caloric deprivation.
* **Mitochondrial Uncoupling Agents:** Structured to cross cellular membranes and safely uncouple the electron transport chain, forcing the cell to burning lipids as heat to track non-shivering thermogenesis parameters.
* **Central Satiety Pathways:** Blended to evaluate the down-regulation of orexigenic peptide expression in the hypothalamus, studying the attenuation of behavioral food-seeking motivation and appetite drive pathways.

### Mechanism of Action
The Slimetry matrix targets complementary metabolic and neurochemical checkpoints to explore advanced cellular signaling and bioenergetics:
* **Upregulation of Lipid Beta-Oxidation:** The active components within Slimetry shift cellular preference toward fatty acid utilization. By stimulating carnitine palmitoyltransferase-1 ($CPT\text{-}1$) expression, it accelerates the transport of long-chain fatty acids into the mitochondria for continuous lipid oxidation ($ \beta\text{-oxidation} $).
* **Mitochondrial Biogenesis & PGC-1α Firing:** Slimetry triggers a downstream signaling cascade that prompts the upregulation of Peroxisome proliferator-activated receptor gamma coactivator 1-alpha ($PGC\text{-}1\alpha$). This master regulator drives the biogenesis of high-density mitochondrial networks within white adipose tissue, modeling the conversion of standard fat into active, energy-burning brown fat matrices.
* **ATP Turnover Rate Acceleration:** At the cellular level, the compound alters baseline mitochondrial efficiency, slightly increasing the rate of Adenosine Triphosphate ($ATP$) turnover. This forces the host system to expand regular metabolic expenditure to maintain basic homeostatic operations.
* **Hypothalamic Satiety Alignment:** Via central pathways, the matrix modulates signaling across the arcuate nucleus, supporting the down-regulation of hunger pathways and allowing for the comprehensive mapping of long-term metabolic adaptation during weight-loss modeling.

### Research Applications
In preclinical and in vitro laboratory models, Slimetry Capsules 26.15mg are actively utilized to investigate:
* High-velocity lipid mobilization, visceral adipose tissue browning kinetics, and systemic metabolic rate repartitioning.
* Intracellular AMPK pathway saturation, PGC-1alpha transcription, and enhanced mitochondrial energy expenditure profiles.
* Central nervous system satiety regulation, appetite pathway attenuation, and behavioral food-reward feedback loops.
* The comparative baseline bioavailability, peak absorption windows, and metabolic rate adaptation of oral small-molecule nutrient repartitioning agents.

Our Slimetry Capsules are precision-manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, high chemical purity, and dependable experimental reproducibility across every research batch.


*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*

Menu

Research Categories